Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Kiora Pharmaceuticals (KPRX)

Annual Return

Over the past 3 years, KPRX has had an average annual return of -20.66%, underperforming the benchmark SPY, which returned +22.77% annual.

Over the past 5 years, KPRX has had an average annual return of -69.80%, underperforming the benchmark SPY, which returned +14% annual.

Over the past 10 years, KPRX has had an average annual return of -57.16%, underperforming the benchmark SPY, which returned +15.53% annual.

Since Jul 31, 2015, KPRX has had an average annual return of -57.22%, underperforming the benchmark SPY, which returned +14.45% annual.

202620252024202320222021202020192018201720162015
+0%+0%+0%-87.50%-94.33%-69.35%-50.75%+43.69%-56.58%-34.34%-40.50%-61.68%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+0%+0%+0%+0%+0%+0%+0%
2025+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%
2024+0%+100%+0%-50.00%+0%+0%+0%+0%+0%+0%+0%+0%+0%
2023+0%+25%-20.00%+25%-50.00%-80.00%+0%+0%+0%+0%+0%+0%-87.50%
2022-48.94%-19.44%+0%-15.52%-16.33%+7.32%-68.18%+28.57%-22.22%+7.14%-46.67%+0%-94.33%
2021+27.83%-12.07%-10.25%-15.09%+3.81%-17.11%-30.68%-26.81%+22.09%-15.71%-20.34%-0%-69.35%
2020-42.72%+0.19%-9.51%+0.21%-2.06%-5.88%-15.18%-0.26%-3.43%-10.38%-5.79%+48.87%-50.75%
2019+4.31%-11.36%-28.95%-4.92%-13.55%-4.27%-13.69%-18.28%+25.32%+23.91%+98.64%+27.77%+43.69%
2018-2.81%-45.22%-33.38%+39.36%+6.22%-5.73%+0.54%+5.10%-44.57%-0%+63.13%-8.19%-56.58%
2017-5.96%+73.51%-4.14%-23.14%-3.58%-27.51%-2.19%-26.09%+18.12%-5.75%-2.08%-0.86%-34.34%

Drawdown analysis of Kiora Pharmaceuticals (KPRX)

The maximum drawdown for the KPRX was -99.99%, occurring on Jun 30, 2023. This drawdown has not yet recovered.

The current KPRX drawdown is -99.99%.

Since Jul 31, 2015 KPRX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Jul 31, 20151992Jun 30, 2023OngoingOngoingOngoing